This content is machine translated Alternative to insulin and GLP1 From the β-cell to the center: the versatile role of amylin Although amylin was discovered decades ago, its importance in everyday clinical practice has long been underestimated. New pharmacological developments are increasingly bringing amylin into the focus of diabetes and obesity...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 11 min This content is machine translated Alternative to insulin and GLP1 From the β-cell to the center: the versatile role of amylin Although amylin was discovered decades ago, its importance in everyday clinical practice has long been underestimated. New pharmacological developments are increasingly bringing amylin into the focus of diabetes and obesity...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 3 min This content is machine translated Adherence of GLP1-RA Half of patients discontinue treatment within a year GLP1 receptor agonists have revolutionized the treatment of obesity, but their effectiveness depends on long-term and continuous use. However, data from Danish health registries presented at EASD 2025 show that...…
View Post 4 min This content is machine translated GLP1-RA therapy Improvement in either weight or HbA1c – but never both Numerous studies show that glucagon-like peptide-1 receptor agonists (GLP1-RA) can significantly reduce the risk of diabetes-related complications and also reduce mortality. Despite their proven efficacy in trial designs, patient response...…
View Post 5 min This content is machine translated Type 2 diabetes Pharmacotherapy can lead to remission Traditionally, the treatment of type 2 diabetes has focused on blood glucose control and the prevention of complications. In the future, these therapeutic approaches could be complemented by another, which,...…
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 5 min This content is machine translated Journal Club Nephrolithiasis and gout: SGLT2i could be an effective supplement Nephrolithiasis and gout are diseases with an increasing global burden and often co-occur with type 2 diabetes mellitus. SGLT2 inhibitors, which were first approved for the treatment of hyperglycemia in…
View Post 3 min This content is machine translated Real-world data from tirzepatide Safety comparable to other GLP1-RA As more people with type 2 diabetes (T2D) take medication to control blood sugar levels and lose weight, safety concerns have arisen. Real-world evidence from the US Food and Drug…
